Literature DB >> 25805003

Peptides and the blood-brain barrier.

William A Banks1.   

Abstract

The demonstration that peptides and regulatory proteins can cross the blood-brain barrier (BBB) is one of the major contributions of Dr. Abba J. Kastin. He was the first to propose that peptides could cross the BBB, the first to show that an endogenous peptide did so, and the first to describe a saturable transport system at the BBB for peptides. His work shows that in crossing the BBB, peptides and regulatory proteins act as informational molecules, informing the brain of peripheral events. Brain-to-blood passage helps to control levels of peptides with the brain and can deliver information in the brain-to-blood direction. He showed that the transporters for peptides and proteins are not static, but respond to developmental and physiological changes and are affected by disease states. As such, the BBB is adaptive to the needs of the CNS, but when that adaption goes awry, the BBB can be a cause of disease. The mechanisms by which peptides and proteins cross the BBB offer opportunities for drug delivery of these substances or their analogs to the brain in the treatment of diseases of the central nervous system. Published by Elsevier Inc.

Entities:  

Keywords:  AJ Kastin; Blood–brain barrier; Cytokines; Delta sleep-inducing peptide; Peptides; Regulatory proteins

Mesh:

Substances:

Year:  2015        PMID: 25805003      PMCID: PMC5354301          DOI: 10.1016/j.peptides.2015.03.010

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  48 in total

1.  Passage of Tyr-MIF-1 from blood to brain.

Authors:  C M Barrera; W A Banks; A J Kastin
Journal:  Brain Res Bull       Date:  1989-12       Impact factor: 4.077

2.  Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum.

Authors:  W A Banks; S A Farr; M E La Scola; J E Morley
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

Review 3.  Cytokine transport across the injured blood-spinal cord barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

4.  Bidirectional saturable transport of LHRH across the blood-brain barrier.

Authors:  C M Barrera; A J Kastin; M B Fasold; W A Banks
Journal:  Am J Physiol       Date:  1991-09

5.  Endothelial cell leptin receptor mutant mice have hyperleptinemia and reduced tissue uptake.

Authors:  Hung Hsuchou; Bhavaani Jayaram; Abba J Kastin; Yuping Wang; Suidong Ouyang; Weihong Pan
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

6.  Evidence that [125I]N-Tyr-delta sleep-inducing peptide crosses the blood-brain barrier by a non-competitive mechanism.

Authors:  W A Banks; A J Kastin; D H Coy
Journal:  Brain Res       Date:  1984-06-03       Impact factor: 3.252

7.  Whole body and brain distribution of [3H]cyclic [D-Pen2,D-Pen5] enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration.

Authors:  S J Weber; D L Greene; V J Hruby; H I Yamamura; F Porreca; T P Davis
Journal:  J Pharmacol Exp Ther       Date:  1992-12       Impact factor: 4.030

8.  Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.

Authors:  W A Banks; A J Kastin; G Komaki; A Arimura
Journal:  J Pharmacol Exp Ther       Date:  1993-11       Impact factor: 4.030

9.  Delta sleep-inducing peptide crosses the blood-brain-barrier in dogs: some correlations with protein binding.

Authors:  W A Banks; A J Kastin; D H Coy
Journal:  Pharmacol Biochem Behav       Date:  1982-11       Impact factor: 3.533

10.  Differential penetration of DSIP peptides into rat brain.

Authors:  A J Kastin; W A Banks; P F Castellanos; C Nissen; D H Coy
Journal:  Pharmacol Biochem Behav       Date:  1982-12       Impact factor: 3.533

View more
  21 in total

Review 1.  Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression.

Authors:  M R Lee; R D Jayant
Journal:  Cell Tissue Res       Date:  2018-12-10       Impact factor: 5.249

Review 2.  Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.

Authors:  Mary R Lee; Matthew C H Rohn; Gianluigi Tanda; Lorenzo Leggio
Journal:  CNS Drugs       Date:  2016-02       Impact factor: 5.749

Review 3.  Oxytocin for the treatment of drug and alcohol use disorders.

Authors:  Mary R Lee; Elise M Weerts
Journal:  Behav Pharmacol       Date:  2016-12       Impact factor: 2.293

4.  A novel CNS-homing peptide for targeting neuroinflammatory lesions in experimental autoimmune encephalomyelitis.

Authors:  Bodhraj Acharya; Rakeshchandra R Meka; Shivaprasad H Venkatesha; Jason R Lees; Tambet Teesalu; Kamal D Moudgil
Journal:  Mol Cell Probes       Date:  2020-02-05       Impact factor: 2.365

Review 5.  Peptide-Liganded G Protein-Coupled Receptors as Neurotherapeutics.

Authors:  Lee E Eiden; Ki Ann Goosens; Kenneth A Jacobson; Lorenzo Leggio; Limei Zhang
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-18

6.  Expression and localization of Inter-alpha Inhibitors in rodent brain.

Authors:  X Chen; L Rivard; S Naqvi; S Nakada; J F Padbury; J Sanchez-Esteban; E G Stopa; Y-P Lim; B S Stonestreet
Journal:  Neuroscience       Date:  2016-03-08       Impact factor: 3.590

Review 7.  Blood-Brain Barriers in Obesity.

Authors:  Elizabeth M Rhea; Therese S Salameh; Aric F Logsdon; Angela J Hanson; Michelle A Erickson; William A Banks
Journal:  AAPS J       Date:  2017-04-10       Impact factor: 4.009

Review 8.  Legend of Weight Loss: a Crosstalk Between the Bariatric Surgery and the Brain.

Authors:  Ziwei Lin; Shen Qu
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

9.  Unnarmicin D, an Anti-inflammatory Cyanobacterial Metabolite with δ and μ Opioid Binding Activity Discovered via a Pipeline Approach Designed to Target Neurotherapeutics.

Authors:  Riley D Kirk; Kassie Picard; Joseph A Christian; Shelby L Johnson; Brenton DeBoef; Matthew J Bertin
Journal:  ACS Chem Neurosci       Date:  2020-12-07       Impact factor: 4.418

10.  Distinguishing Alzheimer's Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis.

Authors:  Jay S Hanas; James R S Hocker; Christian A Vannarath; Megan R Lerner; Scott G Blair; Stan A Lightfoot; Rushie J Hanas; James R Couch; Linda A Hershey
Journal:  Brain Sci       Date:  2021-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.